Screener / SEC EDGAR /CIK 0001428336 /10-K filed Mar 17, 2026, compared with Mar 18, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Business Services

Healthequity, Inc. HQY

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 36 Form 144 notices for $12.8M

10-Q, 10-K and Form 144

What HQY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Sep 22, 2023 to Feb 1, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Gayle Wellborn
member of our board of directors
Adopted 10b5-1 plan Jan 14, 2026 10-K Mar 17, 2026
What the company wrote
On January 14, 2026, Gayle Wellborn, a member of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Wellborn Arrangement”). The Wellborn Arrangement provides for the sale, between April 15, 2026 and December 31, 2026, of up to 2,439 shares of the Company’s common stock held by Ms. Wellborn. The Wellborn Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Adrian Dillon
member of our board of directors
Adopted 10b5-1 plan Dec 20, 2025 10-K Mar 17, 2026
What the company wrote
On December 20, 2025, Adrian Dillon, a member of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Dillon Arrangement”). The Dillon Arrangement provides for the sale, between March 21, 2026 and February 1, 2027, of up to 12,469 shares of the Company’s common stock held by Mr. Dillon, which represent the exercise of expiring stock options and sale of the underlying shares. The Dillon Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Michael Fiore
Executive Vice President and Chief Commercial Officer,
Adopted 10b5-1 plan Oct 14, 2025 10-Q Dec 3, 2025
What the company wrote
On October 14, 2025, Michael Fiore, our Executive Vice President and Chief Commercial Officer, entered into a Rule 10b5-1 trading arrangement (the “Fiore Arrangement”). The Fiore Arrangement provides for the sale, between January 13, 2026 and December 15, 2026, of up to 19,532 aggregate shares of the Company’s common stock held directly by Mr. Fiore. The Fiore Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Delano Ladd
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Jun 12, 2025 10-Q Sep 2, 2025
What the company wrote
On June 12, 2025, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between September 11, 2025 and June 6, 2026, of up to 18,000 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Stephen Neeleman
Founder and Vice Chairman
Adopted 10b5-1 plan Jun 9, 2025 10-Q Sep 2, 2025
What the company wrote
On June 9, 2025, Stephen Neeleman, our Founder and Vice Chairman, entered into a Rule 10b5-1 trading arrangement (the “Neeleman Arrangement”). The Neeleman Arrangement provides for the sale, between September 9, 2025 and September 11, 2026, of up to 54,356 aggregate shares of the Company’s common stock held directly and indirectly by Dr. Neeleman. The Neeleman Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Michael Fiore
Chief Commercial Officer
Adopted 10b5-1 plan Dec 18, 2024 10-K Mar 18, 2025
What the company wrote
On December 18, 2024, Michael Fiore, our Chief Commercial Officer, entered into a Rule 10b5-1 trading arrangement (the “Fiore Arrangement”). The Fiore Arrangement provides for the sale, between March 19, 2025 and December 15, 2025, of up to 20,580 aggregate shares of the Company’s common stock held by Mr. Fiore. The Fiore Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Robert Selander
chairman of our board of directors
Adopted 10b5-1 plan Jul 9, 2024 10-Q Sep 3, 2024
What the company wrote
On July 9, 2024, Robert Selander, chairman of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Selander Arrangement”). The Selander Arrangement provides for the sale, between October 9, 2024 and April 16, 2025, of up to 28,000 aggregate shares of the Company’s common stock held directly by Mr. Selander and the exercise of up to 65,000 stock options. The Selander Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Jon Kessler
President and Chief Executive Officer
Adopted 10b5-1 plan Mar 25, 2024 10-Q Jun 3, 2024
What the company wrote
On March 25, 2024, Jon Kessler, our President and Chief Executive Officer, entered into a Rule 10b5-1 trading arrangement (the “Kessler Arrangement”). The Kessler Arrangement provides for the sale, between June 24, 2024 and November 29, 2024, of up to 85,000 aggregate shares of the Company’s common stock held directly or indirectly by Mr. Kessler. The Kessler Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Stephen Neeleman
Founder and Vice Chairman
Adopted 10b5-1 plan Dec 8, 2023 10-K Mar 22, 2024
What the company wrote
On December 08, 2023, Stephen Neeleman, our Founder and Vice Chairman, entered into a Rule 10b5-1 trading arrangement (the “Neeleman Arrangement”). The Neeleman Arrangement provides for the sale, between December 8, 2023 and July 31, 2024, of up to 70,000 aggregate shares of the Company’s common stock held directly by Dr. Neeleman. The Neeleman Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Delano Ladd
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Sep 22, 2023 10-K Mar 22, 2024
What the company wrote
On September 22, 2023, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between December 22, 2023 and August 30, 2024, of up to 7,643 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Delano Ladd
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Sep 22, 2023 10-Q Dec 5, 2023
What the company wrote
On September 22, 2023, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between December 22, 2023 and August 30, 2024, of up to 7,643 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Show the other 3 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 14 filings checked since Jun 7, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 8, 2026 Michael Gathright
Officer
662 $60K
Oct 8, 2026 Michael Henry Fiore
Former EVP, CCO
2,032 $185K
Oct 8, 2026 Scott Cutler
Officer, Director
1,230 $112K
Oct 8, 2026 Delano Ladd
Officer
1,080 $98K
Oct 8, 2026 James M. Lucania
Officer
2,822 $257K
Oct 8, 2026 Stephen Neeleman
Officer, Director
1,095 $100K
Aug 25, 2026 ADRIAN DILLON
Director
7,632 $804K
Jul 13, 2026 Michael Gathright
Officer
2,270 $211K
Jul 10, 2026 Michael Henry Fiore
Officer
2,045 $194K
Jul 10, 2026 MICHAEL FIORE
Officer
2,354 $223K
Jul 10, 2026 Scott Cutler
Officer, Director
1,238 $118K
Jul 10, 2026 Delano Ladd
Officer
1,087 $103K
Jul 10, 2026 James M. Lucania
Officer
2,839 $270K
Jul 10, 2026 Stephen Neeleman
Officer, Director
1,103 $105K
Jul 2, 2026 MICHAEL FIORE
Officer
2,470 $228K
May 29, 2026 MICHAEL FIORE
Officer
3,142 $284K
May 28, 2026 GAYLE WELLBORN
Director
2,439 $211K
May 28, 2026 DELANO LADD
Officer
7,500 $649K
Apr 8, 2026 Michael Henry Fiore
Officer
3,378 $283K
Apr 8, 2026 Elimelech Rosner
Officer
4,768 $400K
Apr 8, 2026 Scott Cutler
Officer, Director
4,931 $413K
Apr 8, 2026 Delano Ladd
Officer
2,481 $208K
Apr 8, 2026 James M. Lucania
Officer
4,393 $368K
Apr 8, 2026 Stephen Neeleman
Officer, Director
2,559 $215K
Apr 2, 2026 Elimelech Rosner
Officer
18,010 $1.5M
Apr 2, 2026 Delano Ladd
Officer
7,726 $638K
Apr 2, 2026 Stephen Neeleman
Officer, Director
9,292 $767K
Jan 14, 2026 Scott Cutler
Officer, Director
12,496 $1.1M
Jan 13, 2026 Michael Henry Fiore
Officer
1,744 $166K
Jan 13, 2026 Elimelech Rosner
Officer
2,074 $198K
Jan 13, 2026 Delano Ladd
Officer
739 $70K
Jan 13, 2026 James M. Lucania
Officer
2,470 $235K
Jan 13, 2026 Stephen Neeleman
Officer, Director
791 $75K
Dec 19, 2025 DELANO LADD
Officer
4,500 $430K
Dec 18, 2025 ELIMELECH ROSNER
Officer
10,959 $1.0M
Dec 12, 2025 GAYLE F WELLBORN
Director
4,339 $425K
Show the other 28 notices

From the Form 144 XML filed with the SEC, since Dec 12, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HQY/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.